LifeVantage Q1 FY24 revenue $51.4M (-0.8% YoY); adj. EBITDA +41%, adj. EPS $0.13

Lifevantage Corp

2024-Q1 EPS reported $0.05 revenue$51,364,000

Revenue $51.4M, down 0.8% YoY (ex-FX -0.2%). Americas +5.9%, US +6.5%; Asia/Pacific & Europe -16.6% (-14.6% constant currency).
GAAP EPS $0.05 flat YoY; adjusted EPS $0.13 vs $0.06. Adjusted EBITDA $4.0M, up 41.4% from $2.8M.
Total active accounts 137k, down 10.5% YoY (Americas -7.5%, APAC/EU -17.0%). Cash from operations $4.8M vs -$1.3M; no debt.
Dividend $0.035/share declared, payable Dec 15, record Dec 1. FY24 guidance: rev $216M-$226M, adj. EBITDA $16M-$18M, adj. EPS $0.52-$0.62.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Lifevantage Corp reported the first fiscal quarter ended September 30, 2023 results: revenue $51.4 million, net income $0.6 million, EPS $0.05 per diluted share.

Period: the first fiscal quarter ended September 30, 2023
Revenue: $51.4 million
Net income: $0.6 million
EPS: $0.05 per diluted share
Result: reported results

Exact text from the filing

to activate optimal health processes, today reported financial results for its first fiscal quarter ended September 30, 2023. First Quarter Fiscal 2024 Summary*: • Revenue of $51.4 million, a decrease of 0.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was down approximately 0.2%; • Revenue in

View on SEC.gov

Browse all earnings releases →

Lifevantage Corp filing history →

Source: SEC EDGAR

accession 0000849146-23-000205

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.